» Articles » PMID: 36702572

Sex Hormone-Binding Globulin and Risk of Coronary Heart Disease in Men and Women

Overview
Journal Clin Chem
Specialty Biochemistry
Date 2023 Jan 26
PMID 36702572
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The role of sex hormone-binding globulin (SHBG) levels in clinical risk stratification and intervention for coronary heart disease (CHD) remains uncertain. We aimed to examine whether circulating levels of SHBG are predictive of CHD risk in men and women.

Methods: We investigated the association between SHBG and the risk of incident CHD in 128 322 men and 135 103 women free of CHD at baseline in the prospective United Kingdom Biobank (UKB) cohort. The unconfounded associations were estimated using Mendelian randomization (MR) analysis. We further conducted a meta-analysis to integrate currently available prospective evidence. CHD events included nonfatal and fatal myocardial infarction and coronary revascularization.

Results: In the UKB, during a median of 11.7 follow-up years, 10 405 men and 4512 women developed CHD. Serum levels of SHBG were monotonically associated with a decreased risk of CHD in both men (adjusted hazard ratio [HR] per log nmol/L increase in SHBG: 0.88 [0.83-0.94]) and women (HR: 0.89 [0.83-0.96]). MR-based analyses suggested causality and a dose-response relationship of SHBG with CHD risk. A cumulative meta-analysis including 216 417 men and 138 282 women from 11 studies showed that higher levels of SHBG were prospectively associated with decreased CHD risk in men comparing the highest with the lowest quartile: pooled relative risk (RR) 0.81 (0.74-0.89) and women (pooled RR: 0.86 [0.78-0.94]).

Conclusions: Higher circulating SHBG levels were directly and independently predictive of lower CHD risk in both men and women. The utility of SHBG for CHD risk stratification and prediction warrants further study.

Citing Articles

Association between alcohol consumption and incidence of dementia in current drinkers: linear and non-linear mendelian randomization analysis.

Zheng L, Liao W, Luo S, Li B, Liu D, Yun Q EClinicalMedicine. 2024; 76:102810.

PMID: 39290634 PMC: 11405827. DOI: 10.1016/j.eclinm.2024.102810.


Causal validation of the relationship between 35 blood and urine biomarkers and hyperthyroidism: a bidirectional Mendelian randomization study and meta-analysis.

Xu W, Wu J, Chen D, Zhang R, Yang Y Front Endocrinol (Lausanne). 2024; 15:1430798.

PMID: 39188917 PMC: 11345139. DOI: 10.3389/fendo.2024.1430798.


Causal relationship analysis between 35 blood/urine metabolites and gastroesophageal reflux disease: A Mendelian randomization combined meta-analysis study.

Chen D, Xu W, Wen Y, Tan X, Liu J Medicine (Baltimore). 2024; 103(32):e39248.

PMID: 39121258 PMC: 11315488. DOI: 10.1097/MD.0000000000039248.


Association between sex hormone binding globulin and metabolic syndrome in US adults: insights from National Health and Nutrition Examination Survey (NHANES) 2013-2016.

Yang Y, Wang J, Huang Y, Liu Y, Liu S, Liu H Diabetol Metab Syndr. 2024; 16(1):170.

PMID: 39026336 PMC: 11256583. DOI: 10.1186/s13098-024-01398-6.


The association between immune cells and breast cancer: insights from Mendelian randomization and meta-analysis.

Xu W, Zhang T, Zhu Z, Yang Y Int J Surg. 2024; 111(1):230-241.

PMID: 38935111 PMC: 11745723. DOI: 10.1097/JS9.0000000000001840.


References
1.
Davey Smith G, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S, Elwood P . Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation. 2005; 112(3):332-40. DOI: 10.1161/CIRCULATIONAHA.104.489088. View

2.
Ruth K, Day F, Tyrrell J, Thompson D, Wood A, Mahajan A . Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med. 2020; 26(2):252-258. PMC: 7025895. DOI: 10.1038/s41591-020-0751-5. View

3.
Joffe H, Ridker P, Manson J, Cook N, Buring J, Rexrode K . Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. Ann Epidemiol. 2005; 16(2):105-12. DOI: 10.1016/j.annepidem.2005.07.055. View

4.
Luo S, Au Yeung S, Zhao J, Burgess S, Schooling C . Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank. BMJ. 2019; 364:l476. PMC: 6402044. DOI: 10.1136/bmj.l476. View

5.
Ohlsson C, Barrett-Connor E, Bhasin S, Orwoll E, Labrie F, Karlsson M . High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol. 2011; 58(16):1674-81. DOI: 10.1016/j.jacc.2011.07.019. View